Informations générales (source: ClinicalTrials.gov)
Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic (COVID-PRONE)
Observational
University Hospital, Strasbourg, France (Voir sur ClinicalTrials)
mars 2020
juin 2020
29 juin 2024
SARS-CoV-2 induced by COVID 19, involved the hospitalization of 101,932 patients in
France, including 4,007 in intensive care (source: Santé Publique France). Alsace was one
of the most affected regions on the metropolitan territory with a large number of
patients hospitalized at the University Hospital of Strasbourg.
In view of the seriousness of the epidemic and the rapid arrival of new patients
requiring mechanical ventilation, 3 new intensive care units have been created on the NHC
site alone, making it possible to accommodate a maximum of 111 patients (compared to 52
during normal periods).
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil - 67091 - Strasbourg - France | Bob HEGER, MD | Contact (sur clinicalTrials) |
Critères
Tous
Criteria for inclusion :
- Major patient (≥18 years old)
- Patient hospitalized in intensive care at the NHC, diagnosed COVID + and requiring a
VD session of which at least one is performed by the dedicated team.
- patient who has not expressed, after information, his or her opposition to the
re-use of his or her data for the purposes of this research
Exclusion criteria :
- Subject who expressed opposition to participating in the study
- Subject under guardianship, curatorship or safeguarding of justice
- Major patient (≥18 years old)
- Patient hospitalized in intensive care at the NHC, diagnosed COVID + and requiring a
VD session of which at least one is performed by the dedicated team.
- patient who has not expressed, after information, his or her opposition to the
re-use of his or her data for the purposes of this research
Exclusion criteria :
- Subject who expressed opposition to participating in the study
- Subject under guardianship, curatorship or safeguarding of justice